AllovirInc Stock Analysis

AllovirInc Stock Analysis Notes

About 50.0% of the company shares are held by company insiders. The book value of AllovirInc was presently reported as 2.47. The company recorded a loss per share of 1.97. AllovirInc had not issued any dividends in recent years. The entity had 1:10 split on the April 2, 2013. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. For more info on AllovirInc please contact Assaf Katan at 617 433 2605 or go to https://www.allovir.com.

AllovirInc Investment Alerts

AllovirInc Upcoming and Recent Events

AllovirInc Largest EPS Surprises

View All Earnings EstimatesView All Earnings Estimates

AllovirInc SEC Filings

AllovirInc Stock Institutional Investors

Note, although AllovirInc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AllovirInc Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 381.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AllovirInc's market, we take the total number of its shares issued and multiply it by AllovirInc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AllovirInc Profitablity

Management Efficiency

The entity has return on total asset (ROA) of (0.3797) % which means that it has lost $0.3797 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.7502) %, meaning that it created substantial loss on money invested by shareholders. AllovirInc management efficiency ratios could be used to measure how well allovirinc manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/27/2023, Return on Average Assets is likely to drop to -0.73. In addition to that, Return on Average Equity is likely to drop to -0.83. AllovirInc Current Assets are relatively stable at the moment as compared to the past year. AllovirInc reported last year Current Assets of 243.05 Million. As of 03/27/2023, Tangible Assets Book Value per Share is likely to grow to 3.71, while Assets Non Current are likely to drop slightly above 28.2 M.

Technical Drivers

AllovirInc Price Movement Analysis

AllovirInc Insider Trading Activities

AllovirInc Predictive Daily Indicators

AllovirInc Forecast Models

AllovirInc time-series forecasting models is one of many AllovirInc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AllovirInc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how AllovirInc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AllovirInc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as AllovirInc. By using and applying AllovirInc Stock analysis, traders can create a robust methodology for identifying AllovirInc entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AllovirInc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AllovirInc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

AllovirInc stock analysis indicators help investors evaluate how AllovirInc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AllovirInc shares will generate the highest return on investment. By understating and applying AllovirInc stock analysis, traders can identify AllovirInc position entry and exit signals to maximize returns.

Check out Trending Equities. To learn how to invest in AllovirInc Stock please use our How to Invest in AllovirInc guide. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.

Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.